Tag Archives: oncology

Superdisintegrants Market worth $536.5 million by 2023

According to the new market research report Superdisintegrants Market by Product (Modified Starch, Modified Cellulose, Crospovidone, Ion Exchange Resin), Formulation (Tablet, Capsules), Therapeutic Area (Gastrointestinal, Cardiovascular, Neurology, Oncology, Hematology) – Global Forecast to 2023″ published by MarketsandMarkets™, The superdisintegrants market is expected to reach USD 536.5 million by 2023 from an estimated USD 366.4 million in 2018, at a CAGR of 7.9%. The major factors driving the growth of this market include the increasing adoption of orally disintegrating tablets, growing generics market, and emergence of new superdisintegrants for the pharmaceutical industry.